1. Changes to Yucatán Peninsula precipitation associated with salinity and temperature extremes of the Caribbean Sea during the Maya civilization collapse. Issue 1 (December 2017) Authors: Wu, Henry; Felis, Thomas; Scholz, Denis; Giry, Cyril; Kölling, Martin; Jochum, Klaus; Scheffers, Sander Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Innate, T-, and B-Cell Responses in Acute Human Zika Patients. (17th August 2017) Authors: Lai, Lilin; Rouphael, Nadine; Xu, Yongxian; Natrajan, Muktha S; Beck, Allison; Hart, Mari; Feldhammer, Matthew; Feldpausch, Amanda; Hill, Charles; Wu, Henry; Fairley, Jessica K; Lankford-Turner, Pamela; Kasher, Nicole; Rago, Patrick; Hu, Yi-Juan; Edupuganti, Srilatha; Patel, Shital M; Murray, Kri... Journal: Clinical infectious diseases Issue: Volume 66:Number 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practice vs Clinical Trials. (4th December 2021) Authors: Sims, Matthew; Khanna, Sahil; Pardi, Darrell; Feuerstadt, Paul; Berenson, Charles; Wu, Henry; Wang, Elaine E; Wang, Elaine E; McGovern, Barbara; von Moltke, Lisa Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practice vs Clinical Trials. (4th December 2021) Authors: Sims, Matthew; Khanna, Sahil; Pardi, Darrell; Feuerstadt, Paul; Berenson, Charles; Wu, Henry; Wang, Elaine E; Wang, Elaine E; McGovern, Barbara; von Moltke, Lisa Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial. (4th December 2021) Authors: Hohmann, Elizabeth; Feuerstadt, Paul; Oneto, Caterina; Berenson, Charles; Lee, Christine; Pham, Sissi; Zhu, Lei; Reese, Pat Ray; Wu, Henry; Wang, Elaine E; Wang, Elaine E; von Moltke, Lisa; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COVID‐19 and Alzheimer's disease: Meninges‐mediated neuropathology. (December 2021) Authors: Raval, Urdhva; Trageser, Kyle J; Naughton, Sean X; Griggs, Elizabeth; Iqbal, Umar Haris; Wu, Henry; Rahim, Md Al; Harary, Joyce M; Gursahai, Susan; Pasinetti, Giulio Maria Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Causal effects of microglia‐mediated innate immune responses in the pathogenesis of c9orf72 frontotemporal dementia and amyotrophic lateral sclerosis. (December 2021) Authors: Trageser, Kyle J; Smith, Chad; Sebastian, Maria; Iqbal, Umar Haris; Wu, Henry; Rahim, Md Al; Pasinetti, Giulio Maria Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 19. The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial. (4th December 2021) Authors: Hohmann, Elizabeth; Feuerstadt, Paul; Oneto, Caterina; Berenson, Charles; Lee, Christine; Pham, Sissi; Zhu, Lei; Reese, Pat Ray; Wu, Henry; Wang, Elaine E; Wang, Elaine E; von Moltke, Lisa; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 634. Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides difficile Infection (CDI) Compared to Placebo, Regardless of Risk Factors for Recurrence. (4th December 2021) Authors: Cohen, Stuart H; Louie, Thomas J; Sims, Matthew; Pullman, John; Wang, Elaine E; Wang, Elaine E; Wu, Henry; McGovern, Barbara; Brady, Kelly; von Moltke, Lisa Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗